Association between preoperative serum Cystatin‐C levels and postsurgical oncological prognosis in patients with PRCC: A retrospective cohort study
Abstract Objective Cystatin‐C (Cys‐C) is a predictor of several malignancies. However, whether Cys‐C levels predict prognosis in patients with papillary renal cell carcinoma (PRCC) remains uncertain. The aim of this study was to assess the correlation between Cys‐C and clinical outcomes in patients...
Main Authors: | Shiyang Lu, Shijie Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-11-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.4731 |
Similar Items
-
Serum Cystatin C as a Predictor of Acute Kidney Transplant Rejection
by: Fadhil B. Shamkhi, et al.
Published: (2015-10-01) -
Clinical Usefulness of Serum Cystatin C as a Marker of Renal Function
by: Kwang-Sook Woo, et al.
Published: (2014-08-01) -
Increased Serum Cystatin C Levels Were Associated with Depressive Symptoms in Patients with Type 2 Diabetes
by: Huang Y, et al.
Published: (2021-02-01) -
The potential of cystatin C as a predictive biomarker in pulmonary hypertension
by: Anqi Duan, et al.
Published: (2023-08-01) -
Serum cystatin C can be used as a marker of renal function even in patients with intestinal urinary diversion
by: Masahiro Matsuki, et al.
Published: (2015-07-01)